The Pennant Group's (PNTG) "Overweight" Rating Reiterated at Stephens

The Pennant Group (NASDAQ:PNTG - Get Free Report)'s stock had its "overweight" rating reiterated by Stephens in a report issued on Tuesday,Benzinga reports. They presently have a $35.00 price target on the stock. Stephens' price target would indicate a potential upside of 26.49% from the company's previous close.

PNTG has been the subject of a number of other research reports. Truist Financial lifted their price target on shares of The Pennant Group from $28.00 to $32.00 and gave the stock a "hold" rating in a research note on Monday, May 12th. Wells Fargo & Company lifted their price target on shares of The Pennant Group from $30.00 to $31.00 and gave the stock an "equal weight" rating in a research note on Tuesday, June 3rd. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $34.60.

The Pennant Group Stock Down 0.3%

Shares of NASDAQ:PNTG traded down $0.07 during midday trading on Tuesday, reaching $27.67. The company had a trading volume of 192,168 shares, compared to its average volume of 225,839. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.12 and a quick ratio of 1.12. The stock's fifty day moving average price is $27.35 and its 200-day moving average price is $26.78. The stock has a market capitalization of $953.76 million, a P/E ratio of 40.69, a PEG ratio of 2.24 and a beta of 1.51. The Pennant Group has a one year low of $21.18 and a one year high of $37.13.

Insider Buying and Selling at The Pennant Group

In other The Pennant Group news, Director Joanne Stringfield sold 5,000 shares of the business's stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $29.47, for a total transaction of $147,350.00. Following the completion of the sale, the director now owns 30,275 shares in the company, valued at $892,204.25. The trade was a 14.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 5.40% of the stock is owned by insiders.

Institutional Trading of The Pennant Group

Several institutional investors have recently added to or reduced their stakes in the business. Rhumbline Advisers increased its stake in The Pennant Group by 8.6% during the first quarter. Rhumbline Advisers now owns 47,423 shares of the company's stock valued at $1,193,000 after purchasing an additional 3,750 shares during the last quarter. Jane Street Group LLC acquired a new position in shares of The Pennant Group during the first quarter valued at $297,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of The Pennant Group by 4.5% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 81,392 shares of the company's stock valued at $2,047,000 after acquiring an additional 3,507 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of The Pennant Group by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,394 shares of the company's stock valued at $488,000 after acquiring an additional 857 shares during the period. Finally, Bosun Asset Management LLC acquired a new position in shares of The Pennant Group during the first quarter valued at $249,000. Institutional investors own 85.88% of the company's stock.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.